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LETTER TO THE EDITOR 1 
Letter to the editor re Parachini-Winter et al. “A case of canine high‐grade T‐cell lymphoma 2 
immunophenotypically consistent with T‐zone lymphoma” 3 
Dear Editor, 4 
Recently, we have read with interest the article  “A case of canine high‐grade T‐cell lymphoma 5 
immunophenotypically consistent with T‐zone lymphoma” by Parachini-Winter et al. 1 on Veterinary Clinical 6 
Pathology. This report describes an interesting case of canine Peripheral T Cell Lymphoma (PTCL) where 7 
neoplastic cells show a peculiar immunophenotype (CD45neg, CD5pos) with several similarites to T-zone 8 
lymphoma (TZL).  9 
The case is accurately documented and the current literature on the topic is adequately evaluated. 10 
However, some of the conclusions need further discussion in order to avoid incorrect messages to the 11 
readers. 12 
The authors discredit describe the limit of flow cytometry  (FC) in the T zone lymphoma diagnostic work-up 13 
stating that antibodies reactivities led to an incorrect diagnosis of TZL in this dog. Moreover, the authors 14 
suggest the necessity of lymphadenectomy and subsequent histopathological and immunohistochemical 15 
evaluation to diagnose TZL.  16 
Based on our experience, we partially disagree with the aforementioned statement and below the principal 17 
issues are discussed. 18 
The data obtained from cytology and flow cytometry in association with the most significant 19 
clinicopathological features such as complete blood cell count , are often sufficient for a final diagnosis of 20 
TZL with no need for histopathology. Indeed, in the current case description, many clinic-pathological 21 
features are in contrast with the classical presentation of canine TZL that have been reported previously. 22 
First, the size of cells cytologically described as “intermediated to occasionally large” (this was also 23 
confirmed by the high Forward Scatter properties in FC) disagrees with the TZL morphological appearance. 24 
TZL are characterized by small clear cells in most of the published case series . Second, the mitotic index 25 
reported as “1-5 mitotic figure per 50X field” is generally considered as high according to the updated Kiel 26 
classification2. Conversely, by definition TZL are classified as indolent low-grade lymphoma. Third, several 27 
case series reported blood infiltration as an almost constant hematological feature of TZL3, and this was not 28 
the case, even if flow cytometry was not performed on peripheral blood to check for a low percentage of 29 
neoplastic cells. Based on the above and our experience, the diagnosis of TZL should have been considered 30 
as highly improbable in this dog despite CD45 negativity.  31 
Over the last 10 years our caseload recruited about 5000 FC phenotype canine lymphomas and CD45 32 
negativity was very rare in lymphoma subtypes other than TZL, but still, it may occur. In a recent 33 
retrospective case series we have described a dog with extranodal lymphoma where neoplastic cells were 34 
large-sized and CD45 negative, leading to a probable diagnosis of PTCL rather than TZL4. Other authors have 35 
also reported a T-cell lingual lymphoma with similar features5 as also adequately addressed in the present 36 
paper.  37 
The authors state that “this case differs from previous research findings and the potential conclusion that 38 
flow cytometry alone is reliable to diagnose TZL in dogs”.  The conclusion that FC alone is able to diagnose 39 
TZL is an overinterpretation not supported by any of the quoted references. 40 
In contrast in the paper from Martini et al 2016 3, cases with  “a cytological diagnosis of small-clear cell 41 
lymphoma” and a concomitant “CD45-negative small T-cells” phenotype based on FC were enrolled and in 42 
2015, Martini et al6 clearly stated that “the combined use of cytology and FC allows solving the differential 43 
diagnosis between small clear cell lymphoma and non-neoplastic reactive conditions when histopathology is 44 
not available”. Finally, Harris et al 5 described cases  “based on a variable combination of cytology, 45 
histopathology, immunohistochemistry, immunophenotyping via flow cytometry and PCR for antigen 46 
receptor rearrangement assay”.  47 
From all the published data it is evident that an accurate analysis of more than one clinicopathological 48 
aspect is necessary to recognize TZL if lymphadenectomy and subsequent histopathology are not 49 
considered. Furthermore, guidelines from ECLN have reported that FC should always be examined in light 50 
of cytological appearance in order to avoid a mis-diagnosis. 51 
It is not our intention to minimize the importance of histopathology in the diagnosis and classification of 52 
canine lymphoma, as we always describe lymphadenectomy as a fundamental step in the lymphoma 53 
diagnostic workup.  However, we are aware that many clinicians often treat dogs with lymphoma without a 54 
histopathological diagnosis, as shown by a recent survey7 This is particularly true for low-grade lymphomas 55 
in which the indolent nature of the disease tends often to redirect towards non-invasive diagnostic 56 
techniques and a more prudent behavior. 57 
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